-
Sotera Health Announces Secondary Offering of Common Stock
-
Citi Upgrades Sotera Health (SHC) to Buy
-
Citi Downgrades Bio-Rad Labs (BIO) to Neutral
-
Sotera Health Co. (SHC) Announces Pricing of Secondary Offering
-
Sotera Health Announces Pricing of Secondary Offering
-
Sotera Health Co. (SHC) Announces 25M Share Secondary Offering
-
Sotera Health Announces Secondary Offering of Common Stock
-
Sotera Health Reports Fourth-Quarter and Full-Year 2022 Results; Provides 2023 Outlook
-
Sotera Health Reports Fourth-Quarter and Full-Year 2022 Results; Provides 2023 Outlook
-
Citi Says Avantor (AVTR) Selloff is 'Overdone', Upgrades to Buy
-
UPDATE: Citi Downgrades Sotera Health (SHC) to Neutral
-
Sotera Health Co. (SHC) Prices 25M Share Secondary Offering at $27/Sh
-
Sotera Health Announces Pricing of Secondary Offering
-
Sotera Health Announces Pricing of Secondary Offering
-
Sotera Health Co. (SHC) Announces 25M Share Secondary Offering of Common Stock
-
Sotera Health Announces Secondary Offering of Common Stock
-
Sotera Health to Present at Upcoming Healthcare Conferences
-
Sotera Health to Present at Upcoming Healthcare Conferences
-
Sotera Health Announces Closing of Initial Public Offering
-
Sotera Health Announces Closing of Initial Public Offering
-
Sotera Health (SHC) IPO Opens 17% Higher
-
Sotera Health Co. (SHC) Prices 46.6M IPO at $23/Sh
-
Sotera Health Announces Pricing of Initial Public Offering

